Objective: The objective of this study was to examine whether the fetal baroreceptor reflex contributed to the low frequency component (LF: 0.025–0.125 cycles/beat) of fetal heart rate fluctuations. Methods: Sheep fetuses in late gestation with normoxemia were used. The baroreceptor function was expressed as the baroreceptor reflex sensitivity (BRS) based on the change of the R-R interval in response to the elevation of blood pressure by noradrenaline (Nor-Ad). A frequency analysis was conducted by the autoregression method on heart rate fluctuations and blood pressure fluctuations in 300 stable heart beats immediately before the Nor-Ad test. The gain and the coherence from blood pressure LF to heart rate LF were calculated. The correlations between the BRS and the power values of heart rate LF, blood pressure LF, and the gain or the coherence were examined. Results: The BRS and the gain showed a positive correlation (p < 0.01). There was a negative correlation between the heart rate LF and the BRS, and between the blood pressure LF and the BRS (p < 0.01, p < 0.005). Conclusions: This study showed that fetal BRS was involved in the change of LF in fetal heart rate fluctuation. Baroreceptor function should be considered when examining the change of LF domain in fetal heart beat fluctuation.

Keywords:
Fetus, Baroreceptor reflex, Heart rate fluctuation
This content is only available via PDF.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.